Biopharma Co.'s Shares Triple in Value on US$5B License Deal - Streetwise Reports

Retrieved on: 2022-12-07 19:17:57

Tags for this article:

Click the tags to see associated articles and topics

Biopharma Co.'s Shares Triple in Value on US$5B License Deal - Streetwise Reports. View article details on hiswai:

Excerpt

Summit has agreed to pay Akeso an upfront payment of US$500 million, which it plans to finance via an equity rights issuance. Biopharmaceutical ...

Article found on: www.streetwisereports.com